- 301. DOX/PRDL/VCR
- (UMLS (NCI) C0281484) =Therapeutic or Preventive Procedure
| - 331. Doxorubicin Hcl Liposome/Gemcitabine/Vinorelbine
- (UMLS (NCI) C0879571) =Therapeutic or Preventive Procedure
|
- 302. DOX/PRED
- (UMLS (NCI) C0279013) =Therapeutic or Preventive Procedure ;
| - 332. Doxorubicin Hcl Liposome/Ifosfamide
- (UMLS (NCI) C1134566) =Therapeutic or Preventive Procedure
|
- 303. DOX/PRED/VM-26
- (UMLS (NCI) C0279511) =Therapeutic or Preventive Procedure
| - 333. Doxorubicin Hcl Liposome/Interleukin-12
- (UMLS (NCI) C0935798) =Therapeutic or Preventive Procedure
|
- 304. DOX/PRED/VP-16
- (UMLS (NCI) C0279891) =Therapeutic or Preventive Procedure
| - 334. Doxorubicin Hcl Liposome/Methotrexate/Prednisone/Vincristine
- (UMLS (NCI) C0879375) =Therapeutic or Preventive Procedure
|
- 305. DOX/progesterone
- (UMLS (NCI) C0392995) =Therapeutic or Preventive Procedure
| - 335. Doxorubicin HCl Liposome/Paclitaxel
- (UMLS (NCI) C0678066) =Therapeutic or Preventive Procedure ;
|
- 306. DOX/PSC 833
- (UMLS (NCI) C0392966) =Therapeutic or Preventive Procedure ;
| - 336. Doxorubicin HCl Liposome/PSC 833
- (UMLS (NCI) C0677968) =Therapeutic or Preventive Procedure
|
- 307. DOX/QND
- (UMLS (NCI) C0280652) =Therapeutic or Preventive Procedure
| - 337. Doxorubicin HCl Liposome/Topotecan
- (UMLS (NCI) C0678077) =Therapeutic or Preventive Procedure ;
|
- 308. DOX/QND/VP-16
- (UMLS (NCI) C0279040) =Therapeutic or Preventive Procedure
| - 338. Doxorubicin HCl Liposome/Trastuzumab
- (UMLS (NCI) C0879426) =Therapeutic or Preventive Procedure
|
- 309. DOX/SUR
- (UMLS (NCI) C0280983) =Therapeutic or Preventive Procedure
| - 339. Doxorubicin HCl Liposome/VX-853
- (UMLS (NCI) C0677741) =Therapeutic or Preventive Procedure ;
|
- 310. DOX/SZC
- (UMLS (NCI) C0281271) =Therapeutic or Preventive Procedure
| - 340. Doxorubicin Hcl Liposome/ZD0473
- (UMLS (NCI) C0935849) =Therapeutic or Preventive Procedure
|
- 311. DOX/TAX
- (UMLS (NCI) C0280905) =Therapeutic or Preventive Procedure
| - 341. Doxorubicin-HPMA
- [A copolymer conjugate of the anthracycline antineoplastic antibiotic doxorubicin and the water-soluble polymer N-(2-hydroxypropyl) methacrylamide (HPMA). Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids. Conjugation with HPMA improves the therapeutic effects of doxorubicin, by promoting drug accumulation inside tumors, while decreasing systemic toxicity. ( NCI )] (UMLS (NCI) C0114882) =Organic Chemical; Pharmacologic Substance ;
|
- 312. DOX/TOPO
- (UMLS (NCI) C0281396) =Therapeutic or Preventive Procedure ;
| - 342. Doxorubicin/Etoposide/Ifosfamide/Vincristine
- (UMLS (NCI) C0935877) =Therapeutic or Preventive Procedure ;
|
- 313. DOX/Trifluoperazine/VBL/VPAM
- (UMLS (NCI) C0281142) =Therapeutic or Preventive Procedure
| - 343. Doxorubicin/Etoposide/Mitotane/Tariquidar/Vincristine
- (UMLS (NCI) C1328098) =Therapeutic or Preventive Procedure; ;
|
- 314. DOX/TSPA
- (UMLS (NCI) C0280987) =Therapeutic or Preventive Procedure
| - 344. Doxorubicin/Filgrastim/XR9576
- (UMLS (NCI) C0935818) =Therapeutic or Preventive Procedure
|
- 315. DOX/TSPA/VBL
- (UMLS (NCI) C0279686) =Therapeutic or Preventive Procedure
| - 345. Doxorubicin/Hydrocortisone/Methotrexate
- (UMLS (NCI) C0935715) =Therapeutic or Preventive Procedure
|
- 316. DOX/VBL
- (UMLS (NCI) C0280930) =Therapeutic or Preventive Procedure
| - 346. Doxorubicin/Imatinib Mesylate/Pegaspargase/Prednisone/Vincristine
- (UMLS (NCI) C1328056) =Therapeutic or Preventive Procedure; ;
|
- 317. DOX/VBL/VP-16
- (UMLS (NCI) C0255874) =Therapeutic or Preventive Procedure
| - 347. Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vinblastine
- (UMLS (NCI) C1327949) =Therapeutic or Preventive Procedure; ;
|
- 318. DOX/VCR/VP-16
- (UMLS (NCI) C0078136) =Therapeutic or Preventive Procedure
| - 348. Doxorubicin/Methotrexate/Pegaspargase/Vincristine
- (UMLS (NCI) C0879560) =Therapeutic or Preventive Procedure
|
- 319. DOX/VCR/VX-710
- (UMLS (NCI) C0796603) Doxorubicin/Vincristine/VX-710 =Therapeutic or Preventive Procedure
| - 349. Doxorubicin/Motexafin Gadolinium
- (UMLS (NCI) C1134645) =Therapeutic or Preventive Procedure
|
- 320. DOX/VNB
- (UMLS (NCI) C0281256) =Therapeutic or Preventive Procedure ;
| - 350. Doxorubicin/Oblimersen
- (UMLS (NCI) C1327786) =Therapeutic or Preventive Procedure ;
|
- 321. DOX/VPAM
- (UMLS (NCI) C0281009) =Therapeutic or Preventive Procedure
| - 351. Doxorubicin/Octreotide
- (UMLS (NCI) C0935743) =Therapeutic or Preventive Procedure
|
- 322. DOX/VX-710
- (UMLS (NCI) C0338355) =Therapeutic or Preventive Procedure ;
| - 352. Doxorubicin/Ranpirnase
- (UMLS (NCI) C0879256) =Therapeutic or Preventive Procedure
|
- 323. Doxacurium Chloride
- (UMLS (NCI) C0114872) =Organic Chemical; Pharmacologic Substance ;
=doxacurium;
=DOXACURIUM CHLORIDE 1 MG/ML | - 353. Doxorubicin/Strontium Chloride Sr 89
- (UMLS (NCI) C1134484) =Therapeutic or Preventive Procedure
|
- 324. DOXAPRAM
- [A respiratory stimulant with analeptic activity. Doxapram, independent of oxygen levels, directly stimulates the peripheral carotid chemoreceptors, possibly by inhibiting the potassium channels of type I cells within the carotid body, thereby stimulating catecholamines release. This results in the prevention or reversal of both narcotic- and CNS depressant-induced respiratory depression. ( NCI )] (UMLS (NCI) C0013084) =Organic Chemical; Pharmacologic Substance ;
=Pyrrolidinones;
[RE900] RESPIRATORY AGENTS, OTHER =1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone Monohydrochloride, Monohydrate | - 354. Doxorubicin/SU5416
- (UMLS (NCI) C0879494) =Therapeutic or Preventive Procedure
|
- 325. DOXAZOSIN
- [A quinazoline with antihypertensive and antineoplastic properties. Doxazosin is an alpha-adrenergic antagonist that selectively inhibits alpha-1 adrenergic receptors. Blockages of the alpha-1 adrenergic action on the vascular smooth muscles lead to a decrease in vascular resistance and antihypertensive activity. This agent also shows high affinity to alpha-1c adrenoceptor, the predominant functional type in the prostate, which may partially attribute to its effect in treatment of benign prostatic hyperplasia. Furthermore, doxazosin induces apoptosis in prostate cancer cells mediated through inhibition of protein kinase B (PKB)/Akt-signaling death receptor regulatory pathway. ( NCI )] (UMLS (NCI) C0114873) =Organic Chemical; Pharmacologic Substance ;
=1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine;
[CV150] ALPHA-BLOCKERS/RELATED =DOXAZOSIN MESYLATE | - 355. Doxpicomine
- (UMLS (NCI) C0058730) =Organic Chemical; Pharmacologic Substance
|
- 326. Doxefazepam
- (UMLS (NCI) C0114875) =Organic Chemical; Pharmacologic Substance ;
| - 356. doxycycline
- [An antibiotic drug used to treat infection. ( NCI )] (UMLS (CSP) C0013090) =Organic Chemical; Antibiotic =[AM250] TETRACYCLINES;
=DOXYCYCLINE HYCLATE;
DOXYCYCLINE CALCIUM;
DOXYCYCLINE MONOHYDRATE |
- 327. doxepin
- [A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. ( MSH )] (UMLS (CSP) C0013085) =Organic Chemical; Pharmacologic Substance ;
=[CN601] TRICYCLIC ANTIDEPRESSANTS;
Dibenzoxepins;
[DE900] DERMATOLOGICALS, TOPICAL OTHER;
=DOXEPIN HYDROCHLORIDE | - 357. DOXYCYCLINE HYCLATE
- [The hyclate salt form of doxycycline, a synthetic, broad-spectrum tetracycline antibiotic exhibiting antimicrobial activity. Doxycycline hyclate binds reversibly to the 30S ribosomal subunit, possibly to the 50S ribosomal subunit as well, thereby blocking the binding of aminoacyl-tRNA to the mRNA-ribosome complex. This leads to an inhibition of protein synthesis. In addition, this agent has exhibited inhibition of collagenase activity. ( NCI )] (UMLS (NCI) C0058731) =Organic Chemical; Antibiotic =doxycycline;
=DOXYCYCLINE CALCIUM;
DOXYCYCLINE MONOHYDRATE;
DOXYCYCLINE HYCLATE 100 MG;
DOXYCYCLINE HYCLATE 50 MG;
DOXYCYCLINE HYCLATE 200 MG;
DOXYCYCLINE HYCLATE 20 MG |
- 328. doxil
- [ ] (UMLS (CSP) C0279284) =Organic Chemical; Pharmacologic Substance
| - 358. Doxycycline Hydrochloride
- [The hydrochloride salt form of doxycycline exhibiting antimicrobial activity. Doxycycline blocks binding of aminoacyl-tRNA to the mRNA-ribosome complex, thereby inhibiting protein synthesis. In addition, this agent has exhibited inhibition of collagenase activity. (NCI) ( NCI )] (UMLS (NCI) C0771947) =Organic Chemical; Antibiotic ;
|
- 329. Doxorubicin HCl Liposome/Etoposide
- (UMLS (NCI) C0678096) =Therapeutic or Preventive Procedure
| - 359.
- [use for measured amounts of chemicals. ( CSP )] (UMLS (NCI) C0178602) =Quantitative Concept =Pharmacologic;
=Overdose;
radiation therapy dosage;
drug administration rate/duration |
- 330. Doxorubicin Hcl Liposome/Gemcitabine
- (UMLS (NCI) C0879589) =Therapeutic or Preventive Procedure
| |
home
